Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Total Liabilities
Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has total liabilities worth CN¥927.61 Million CNY (≈ $135.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300636 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Jiangxi Synergy Pharmaceutical Co Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Jiangxi Synergy Pharmaceutical Co Ltd.
Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Belo Sun Mining Corp.
TO:BSX
|
Canada | CA$2.05 Million |
|
LandOcean Energy Services Co
SHE:300157
|
China | CN¥1.84 Billion |
|
Deep Fission, Inc. Common Stock
NASDAQ:FISN
|
USA | $8.55 Million |
|
Anhui Wantong Technology Co Ltd
SHE:002331
|
China | CN¥1.56 Billion |
|
Shanxi Yongdong Chemistry Industry Co Ltd
SHE:002753
|
China | CN¥1.03 Billion |
|
Beijing Transtrue Technology Inc
SHE:002771
|
China | CN¥300.66 Million |
|
Ginkgo Bioworks Holdings
NYSE:DNA
|
USA | $569.76 Million |
|
Star Gas Partners LP
NYSE:SGU
|
USA | $621.24 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Jiangxi Synergy Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300636 net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangxi Synergy Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total liabilities of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥955.80 Million ≈ $139.86 Million |
-5.44% |
| 2024-12-31 | CN¥1.01 Billion ≈ $147.91 Million |
+1.59% |
| 2023-12-31 | CN¥994.99 Million ≈ $145.60 Million |
+5.94% |
| 2022-12-31 | CN¥939.19 Million ≈ $137.43 Million |
-7.80% |
| 2021-12-31 | CN¥1.02 Billion ≈ $149.06 Million |
+56.43% |
| 2020-12-31 | CN¥651.17 Million ≈ $95.29 Million |
+110.46% |
| 2019-12-31 | CN¥309.40 Million ≈ $45.28 Million |
+112.71% |
| 2018-12-31 | CN¥145.46 Million ≈ $21.29 Million |
+70.77% |
| 2017-12-31 | CN¥85.18 Million ≈ $12.46 Million |
-25.48% |
| 2016-12-31 | CN¥114.31 Million ≈ $16.73 Million |
+12.08% |
| 2015-12-31 | CN¥101.99 Million ≈ $14.92 Million |
-26.77% |
| 2014-12-31 | CN¥139.28 Million ≈ $20.38 Million |
-11.07% |
| 2013-12-31 | CN¥156.62 Million ≈ $22.92 Million |
+9.28% |
| 2012-12-31 | CN¥143.31 Million ≈ $20.97 Million |
-- |
About Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals in China and internationally. The company offers API products for anti-epilepsy and pain treatment, anti-inflammatory, gastrointestinal, anti-hypertension, anti-gout, anti-… Read more